Glaucoma News

Immunovant’s Batoclimab Misses Key Goal: What Investors Should Do Now The high-stakes world of biotech investing is a rollercoaster of hope and data. For shareholders of Immunovant (NASDAQ: IMVT), the ride took a sharp downward turn recently with the announcement that its lead drug candidate, batoclimab, failed to meet its primary endpoint in a crucial […]

AI Chatbots Repeatedly Spread a Fake Eye Condition as Real In an era where we increasingly turn to AI for quick answers, a recent experiment has delivered a sobering reality check. Researchers from Canada and the UK decided to test a simple, yet profound, question: if you invent a fake medical condition and plant it

Senju Launches Innovative First-in-Class Dry Eye Drug in Japan For the millions in Japan suffering from the persistent discomfort of dry eye disease (DED), a new era of treatment has dawned. Senju Pharmaceutical Co., Ltd. has officially launched **TWYNA®**, a groundbreaking first-in-class drug offering a novel mechanism of action that moves beyond simple lubrication to

Your Guide to Dry Eye Disease: Symptoms, Causes, and Modern Treatments Do you frequently experience a gritty, burning, or tired feeling in your eyes? Does your vision sometimes blur, especially when reading or using a computer? You might be among the millions of people worldwide living with Dry Eye Disease (DED), a common and often

Seafood Virus Linked to Chronic Human Eye Disease Discovery For years, patients suffering from a persistent, inflammatory eye condition have faced a frustrating diagnostic journey. The symptoms—chronic redness, pain, light sensitivity, and blurred vision—are clear, but a definitive cause has often remained elusive. Now, a groundbreaking study has cast a new line of inquiry into

Massive Eye Drop Recall Exposes Critical FDA and Manufacturing Failures A recent, sweeping recall of over two dozen brands of eye drops has shaken consumer confidence and illuminated deep, systemic cracks in the regulatory and manufacturing safeguards meant to protect public health. What began as isolated incidents of contamination has exploded into one of the

Eye Care Professionals Face High Rates of Dry Eye Disease When you visit an optometrist or ophthalmologist for a scratchy, burning sensation in your eyes, you trust their expert diagnosis and treatment plan. But what if the very person helping you manage your dry eye disease (DED) is silently battling the same condition? A surprising

Massive Eye Drop Recall Exposes Critical FDA and Manufacturing Failures A recent, sweeping recall of over two dozen brands of eye drops has done more than just clear pharmacy shelves. It has ripped the bandage off a festering wound in the U.S. healthcare system: critical failures in pharmaceutical manufacturing oversight and a strained Food and

AIIMS Proposes Lactoferrin Milk Protein Tablet for Dry Eye Relief For millions grappling with the persistent discomfort of dry eye disease, relief has often been a revolving door of eye drops, gels, and lifestyle adjustments. Now, a groundbreaking proposal from one of India’s premier medical institutions, the All India Institute of Medical Sciences (AIIMS), is

Amgen’s On-Body Injector for Tepezza Succeeds in Thyroid Eye Disease Trial For patients battling the painful and vision-threatening symptoms of Thyroid Eye Disease (TED), the breakthrough drug Tepezza (teprotumumab) has been a game-changer. However, its administration—eight separate 90-minute IV infusions over several months—has been a significant logistical hurdle. Now, a new chapter is beginning. Amgen